ArticleIJU case reports2019

Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib.

Ryota Morinaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.